| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/02/2023 | 51.93% | HC Wainwright & Co. | → $5.5 | Reiterates | Buy → Buy |
| 05/03/2023 | 51.93% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
| 03/10/2023 | 51.93% | HC Wainwright & Co. | → $5.5 | Reiterates | → Buy |
| 11/04/2022 | 51.93% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 05/04/2022 | 65.75% | B. Riley Securities | $7 → $6 | Maintains | Buy |
| 05/04/2022 | 148.62% | HC Wainwright & Co. | $13 → $9 | Maintains | Buy |
| 09/17/2020 | 314.36% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 09/01/2020 | 314.36% | SVB Leerink | → $15 | Initiates Coverage On | → Outperform |
| 05/06/2020 | 341.99% | B. Riley Securities | $12 → $16 | Maintains | Buy |
| 05/06/2020 | 286.74% | HC Wainwright & Co. | $13 → $14 | Maintains | Buy |
What is the target price for CytoSorbents (CTSO)?
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by HC Wainwright & Co. on August 2, 2023. The analyst firm set a price target for $5.50 expecting CTSO to rise to within 12 months (a possible 51.93% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CytoSorbents (CTSO)?
The latest analyst rating for CytoSorbents (NASDAQ: CTSO) was provided by HC Wainwright & Co., and CytoSorbents reiterated their buy rating.
When is the next analyst rating going to be posted or updated for CytoSorbents (CTSO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on August 2, 2023 so you should expect the next rating to be made available sometime around August 2, 2024.
Is the Analyst Rating CytoSorbents (CTSO) correct?
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a reiterated with a price target of $0.00 to $5.50. The current price CytoSorbents (CTSO) is trading at is $3.62, which is within the analyst's predicted range.